As of Oct 19
| +0.03 / +1.12%|
The 3 analysts offering 12-month price forecasts for Fibrocell Science Inc have a median target of 7.50, with a high estimate of 7.60 and a low estimate of 7.00. The median estimate represents a +175.74% increase from the last price of 2.72.
The current consensus among 3 polled investment analysts is to Buy stock in Fibrocell Science Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.